| Autor | Nasiri, M. J. | |
| Autor | Silva, D. R. | |
| Autor | Rommasi, F. | |
| Autor | Zahmatkesh, M. M. | |
| Autor | Tajabadi, Z. | |
| Autor | Khelghati, F. | |
| Autor | Sarmastzadeh, T. | |
| Autor | Centis, R. | |
| Autor | D’Ambrosio, L. | |
| Autor | Bombarda, S. | |
| Autor | Dalcolmo, M. P. | |
| Autor | Galvão, T. | |
| Autor | Mello, F.C. de Queiroz | |
| Autor | Rabahi, M. F. | |
| Autor | Pontali, E. | |
| Autor | Solovic, I. | |
| Autor | Tadolini, M. | |
| Autor | Marconi, L. | |
| Autor | Tiberi, S. | |
| Autor | Boom, M. van den | |
| Autor | Sotgiu, G. | |
| Autor | Migliori, G. B. | |
| Data de acesso | 2025-02-10T16:39:11Z | |
| Data de disponibilização | 2025-02-10T16:39:11Z | |
| Data do publicação | 2023 | |
| Citação | NASIRI, M. J. et al. Vaccination in post-tuberculosis lung disease management: A review of the evidence. Pulmonology, p. 1-15, 2023. | en_US |
| ISSN | 2531-0437 | en_US |
| URI | https://www.arca.fiocruz.br/handle/icict/68497 | |
| Idioma | por | en_US |
| Editor | Taylor and Francis Group | en_US |
| Direito Autoral | open access | en_US |
| Título | Vaccination in post-tuberculosis lung disease management: A review of the evidence | en_US |
| Tipo do documento | Article | en_US |
| DOI | 10.1016/j.pulmoe.2023.07.002 | |
| Resumo em Inglês | Introduction and objectives: Post-tuberculosis lung disease (PTLD), as other chronic respiratory disorders, may have infectious complications; some of them can be prevented with vaccinations. So far, no document has discussed the potential role of vaccination in PTLD. Therefore, the objective of this review was to describe vaccination recommendations to prevent infections potentially capable of complicating PTLD. Materials and methods: A non-systematic review of the literature was conducted. The following keywords were used: tuberculosis, vaccination, vaccines and PTLD. PubMed/MEDLINE and Embase were used as the search engine, focusing on English-language literature only. Results: We identified 9 vaccines potentially useful in PTLD. Influenza, pneumococcal and antiCOVID-19 vaccinations should be recommended. Patients with PTLD can also benefit from vaccination against shingles. Vaccination against pertussis is mainly relevant during childhood. Diphtheria, tetanus and measles vaccination are recommended for general population and should be considered in patients with PTLD not previously vaccinated. Tdap (Tetanus, diphtheria, and pertussis) booster should be repeated in every adult every ten years. Vaccination against BCG retains its importance during early childhood in countries where TB is endemic. Conclusions: Vaccination deserves to be considered among the strategies to prevent and/or mitigate PTLD complications. Further evidence is necessary to better understand which vaccines have the greatest impact and cost-benefit. | en_US |
| Afiliação | Shahid Beheshti University of Medical Sciences. School of Medicine. Department of Microbiology. Tehran, Iran. | en_US |
| Afiliação | Universidade Federal do Rio Grande do Sul. Faculdade de Medicina. Porto Alegre, RS, Brasil. | en_US |
| Afiliação | Shahid Beheshti University of Medical Sciences. School of Medicine. Department of Microbiology. Tehran, Iran. | en_US |
| Afiliação | Shahid Beheshti University of Medical Sciences. School of Medicine. Department of Microbiology. Tehran, Iran. | en_US |
| Afiliação | Shahid Beheshti University of Medical Sciences. School of Medicine. Department of Microbiology. Tehran, Iran. | en_US |
| Afiliação | Shahid Beheshti University of Medical Sciences. School of Medicine. Department of Microbiology. Tehran, Iran. | en_US |
| Afiliação | Shahid Beheshti University of Medical Sciences. School of Medicine. Department of Microbiology. Tehran, Iran. | en_US |
| Afiliação | Servizio di Epidemiologia Clinica delle Malattie Respiratorie. Istituti Clinici Scientifici Maugeri IRCCS. Tradate, Italy. | en_US |
| Afiliação | Public Health Consulting Group. Lugano, Switzerland. | en_US |
| Afiliação | Secretaria de Estado da Saúde de São Paulo. Programa de Controle da Tuberculose. São Paulo, SP, Brasil. | en_US |
| Afiliação | Fundação Oswaldo Cruz. Escola Nacional de Saúde Pública Sérgio Arouca. Centro de Referência Professor Hélio Fraga. Rio de Janeiro, RJ, Brasil. | en_US |
| Afiliação | Hospital Especializado Octavio Mangabeira. Secretaria de Saúde do Estado da Bahia. Serviço de Pneumologia. Salvador, BA, Brasil. | en_US |
| Afiliação | Universidade Federal do Rio de Janeiro. Instituto de Doenças do Tórax. Rio de Janeiro, RJ, Brasil. | en_US |
| Afiliação | Universidade Federal de Goiás. Faculdade de Medicina. Goiânia, GO, Brasil. | en_US |
| Afiliação | Galliera Hospital. Department of Infectious Diseases. Genoa, Italy. | en_US |
| Afiliação | Catholic University. Faculty of Health. Department of Public Health. Ruzomberok, Slovakia / National Institute of Tuberculosis. Pulmonary Diseases and Thoracic Surgery. Vysne Hagy, Slovakia. | en_US |
| Afiliação | IRCCS Azienda Ospedaliero-Universitaria di Bologna. Infectious Diseases Unit. Bologna, Italy / Alma Mater Studiorum University of Bologna. Department of Medical and Surgical Sciences. Bologna, Italy. | en_US |
| Afiliação | IRCCS Azienda Ospedaliero-Universitaria di Bologna. Infectious Diseases Unit. Bologna, Italy. | en_US |
| Afiliação | Queen Mary University of London. Blizard Institute. Barts and the London School of Medicine and Dentistry. United Kingdom. | en_US |
| Afiliação | World Health Organization. Regional Office for the Eastern Mediterranean Region. Cairo, Egypt. | en_US |
| Afiliação | University of Sassari. Department of Medicine, Surgery and Pharmacy. Clinical Epidemiology and Medical Statistics Unit. Italy. | en_US |
| Palavras-chave em inglês | Mycobacterium tuberculosis | en_US |
| Palavras-chave em inglês | Post-tuberculosis lung disease | en_US |
| Palavras-chave em inglês | Respiratory infections | en_US |
| Palavras-chave em inglês | Vaccination | en_US |
